publication venue for
- Cost-effectiveness analysis of ritonavir boosted nirmatrelvir for adult outpatients with mild to moderate COVID-19 in a European health system 2023
- Deep vein thrombosis symptoms and 30-day mortality in acute pulmonary embolism. 43-51. 2023
- Venous thromboembolism characteristics, treatment and outcomes in young adults: Findings from the RIETE registry. 27-33. 2023
- Deep vein thrombosis symptoms and 30-day mortality in acute pulmonary embolism.. 780-788. 2022
- A one-year risk score to predict all-cause mortality in hypertensive inpatients. 77-83. 2019 ... Más